According to Evoke Pharma 's latest financial reports the company's current revenue (TTM) is $5.18 M. In 2022 the company made a revenue of $2.5 M an increase over the years 2021 revenue that were of $1.61 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $5.18 M | 106.51% |
2022 | $2.5 M | 55.04% |
2021 | $1.61 M | 6929% |
2020 | $0.02 M | |
2019 | N/A | |
2018 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A | |
2012 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ANI Pharmaceuticals ANIP | $0.48 B | 9,296.85% | ๐บ๐ธ USA |
Amphastar Pharmaceuticals AMPH | $0.64 B | 12,338.55% | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | $0.21 B | 4,029.63% | ๐บ๐ธ USA |
Ironwood Pharmaceuticals
IRWD | $0.44 B | 8,445.97% | ๐บ๐ธ USA |